205 related articles for article (PubMed ID: 26905603)
1. Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Burr NE; Hull MA; Subramanian V
J Clin Gastroenterol; 2017 Mar; 51(3):247-253. PubMed ID: 26905603
[TBL] [Abstract][Full Text] [Related]
2. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
Tang J; Sharif O; Pai C; Silverman AL
Dig Dis Sci; 2010 Jun; 55(6):1696-703. PubMed ID: 19705280
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
5. Folic acid intake and folate status and colorectal cancer risk: A systematic review and meta-analysis.
Moazzen S; Dolatkhah R; Tabrizi JS; Shaarbafi J; Alizadeh BZ; de Bock GH; Dastgiri S
Clin Nutr; 2018 Dec; 37(6 Pt A):1926-1934. PubMed ID: 29132834
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
8. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
Burr NE; Hull MA; Subramanian V
World J Gastroenterol; 2016 Apr; 22(13):3679-86. PubMed ID: 27053860
[TBL] [Abstract][Full Text] [Related]
9. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
Diculescu M; Ciocîrlan M; Ciocîrlan M; Piţigoi D; Becheanu G; Croitoru A; Spanache S
Rom J Gastroenterol; 2003 Dec; 12(4):283-6. PubMed ID: 14726972
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease.
Lu MJ; Qiu XY; Mao XQ; Li XT; Zhang HJ
Aliment Pharmacol Ther; 2018 Feb; 47(3):318-331. PubMed ID: 29205426
[TBL] [Abstract][Full Text] [Related]
11. Folate and colorectal cancer: an evidence-based critical review.
Kim YI
Mol Nutr Food Res; 2007 Mar; 51(3):267-92. PubMed ID: 17295418
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials.
Qin T; Du M; Du H; Shu Y; Wang M; Zhu L
Sci Rep; 2015 Jul; 5():12044. PubMed ID: 26131763
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
[TBL] [Abstract][Full Text] [Related]
14. Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
Ratajczak AE; Szymczak-Tomczak A; Rychter AM; Zawada A; Dobrowolska A; Krela-Kaźmierczak I
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836291
[TBL] [Abstract][Full Text] [Related]
15. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
[TBL] [Abstract][Full Text] [Related]
16. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis.
Kennedy DA; Stern SJ; Moretti M; Matok I; Sarkar M; Nickel C; Koren G
Cancer Epidemiol; 2011 Feb; 35(1):2-10. PubMed ID: 21177150
[TBL] [Abstract][Full Text] [Related]
17. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminosalicylic acid and chemoprevention: does it work?
Lopez A; Peyrin-Biroulet L
Dig Dis; 2013; 31(2):248-53. PubMed ID: 24030235
[TBL] [Abstract][Full Text] [Related]
19. The role of dietary supplements in inflammatory bowel disease: a systematic review.
Rossi RE; Whyand T; Murray CD; Hamilton MI; Conte D; Caplin ME
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1357-1364. PubMed ID: 27769076
[TBL] [Abstract][Full Text] [Related]
20. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
